Breathe Well Live Well
|
Teva's injectable asthma biologic approved by FDA
The Pharmaceutical Journal The biologic treatment, which is given as a four-weekly infusion alongside other drugs, is indicated to help those patients with severe asthma who still have serious asthma attacks despite being on regular medication. It is expected to be launched in … |
View full post on asthma – Google News
The Inquisitr |
Asthma Attacks Face Newly Approved Super Treatment 'Cinqair'
The Inquisitr Asthma attacks have a new opponent. And from clinical reports, asthma treatment Cinqair may be quite the formidable remedy. Although, there are side effects. Humans need adequate air flows in order to function properly. Yet, asthma's objective goes … FDA approves Cinqair to treat severe asthma FDA approves new drug Cinqair to be used against Asthma Reslizumab (Cinqair) Approved to Treat Severe Asthma |
View full post on asthma – Google News
The Inquisitr |
Asthma Attack Faces Newly Approved Super Treatment 'Cinqair'
The Inquisitr Asthma attacks have a new opponent. And from clinical reports, asthma treatment Cinqair may be quite the formidable remedy. Although, there are side effects. Humans need adequate air flows in order to function properly. Yet, asthma's objective goes … FDA approves Cinqair to treat severe asthma Reslizumab (Cinqair) Approved to Treat Severe Asthma Teva's Cinqair Approved for Severe Asthma |
View full post on asthma – Google News
International Business Times |
Ajanta Pharma's Generic Anti-Asthma Chewable Tablets Approved By US FDA
International Business Times According to U.S. National Library of Medicine, Montelukast is used to prevent chest tightness, difficulty in breathing and wheezing and coughing caused by asthma. In addition, it is used to prevent the symptoms associated with seasonal allergies and … Ajanta Pharma launches generic asthma treatment tablets in US Ajanta Pharma launches generic asthma treatment tablets Ajanta Pharma launches anti-asthma tablets in US |
View full post on asthma – Google News
|
First-in-class biologic maintenance therapy approved for severe asthma
ModernMedicine Nucala, developed by GlaxoSmithKline, is an interleukin-5 (IL-5) antagonist monoclonal antibody that reduces the production and survival of esosinophils, which are one of the inflammatory cell types involved in asthma. The biologic is to be … |
View full post on asthma – Google News
|
Nucala approved to treat severe asthma
Examiner.com The FDA has approved Nucala (mepolizumab) for use with other asthma medicines for the maintenance treatment of asthma in patients age 12 years and older with a history severe attacks (exacerbations) despite receiving their current asthma medicines. |
View full post on asthma – Google News
|
Spiriva Respimat Now Approved for Asthma
Pharmacy Times The FDA has added an asthma indication to Boehringer Ingelheim's tiotropium bromide inhalation spray (Spiriva Respimat). This long-acting muscarinic antagonist (LAMA) was originally approved in September 2014 for the maintenance treatment of chronic … FDA approves Spiriva Respimat for asthma in adults, adolescents |
View full post on asthma – Google News
Lung Disease News |
Breo Ellipta Now Approved as Asthma Treatment for Adult Patients in Canada
Lung Disease News GlaxoSmithKline (GSK) and VIBATIV® (telavancin) developer Theravance Biopharma, have just been granted Canadian approval for Breo Ellipta, a once-a-day maintenance treatment for asthma in patients who are at least 18 years old and have reversible … |
View full post on asthma – Google News
Madison.com |
Propeller Health's asthma monitor is approved for more devices
Madison.com Propeller's sensors track when and where people with asthma and chronic obstructive pulmonary disease use their inhalers. The idea is to help them understand what triggers an attack and control their symptoms. The latest federal clearances allow use of … FDA Clears 2 Propeller Health Inhaler Devices for Asthma, COPD FDA Clears 2 New Propeller Health Devices That Track Respiratory Meds Propeller Health Receives FDA Clearance For The Propeller Platform In … |
View full post on asthma – Google News
Madison.com |
Propeller Health's asthma monitor is approved for more devices : Wsj – Madison.com
Madison.com Executive Q&A: Putting a cap on asthma. David Van Sickle, 44, heads Propeller Health, a Madison company whose sensor and app technology is designed to reduce asthma attacks and ease … Read more … |
View full post on asthma – Google News